Evidence map›Paper›PMID 39064723›Full record

Observational studyNutrients2024

Improvement of Metabolic-Associated Fatty Liver Disease by Magnetic Resonance Spectroscopy in Morbidly Obese Women Undergoing Roux-en-Y Gastric Bypass, following a Postoperative Mediterranean-like Diet.

Jaime Ruiz-Tovar, Carolina Llavero, Maria Rodriguez-Ortega, Nuria M De Castro, Maria Cristina Martín-Crespo, Gema Escobar-Aguilar, Ana Martin-Nieto, Gilberto Gonzalez

Abstract readObservational Study
In one paragraph

Observational study in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jaime Ruiz-TovarSan Juan de Dios Foundation, 28036 Madrid, Spain.ORCID 0000-0002-8505-2605
Carolina LlaveroObesity Unit, Garcilaso Clinic, 28010 Madrid, Spain.
Maria Rodriguez-OrtegaSan Juan de Dios Foundation, 28036 Madrid, Spain.ORCID 0000-0002-3721-9626
Nuria M De CastroSan Juan de Dios Foundation, 28036 Madrid, Spain.
Maria Cristina Martín-CrespoSan Juan de Dios Foundation, 28036 Madrid, Spain.
Gema Escobar-AguilarSan Juan de Dios Foundation, 28036 Madrid, Spain.
Ana Martin-NietoSan Juan de Dios Foundation, 28036 Madrid, Spain.ORCID 0000-0003-0252-8557
Gilberto GonzalezHospital Real San José, Guadalajara 19001, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Bariatric surgery has demonstrated the capacity to improve metabolic-associated fatty liver disease (MAFLD) in patients with morbid obesity. In addition, the Mediterranean diet contains anti-inflammatory, anti-oxidative, and anti-fibrotic components, promoting a beneficial effect on MAFLD. This study aimed to assess the improvement of MAFLD, specifically liver steatosis, in morbidly obese patients undergoing Roux-en-Y gastric bypass (RYGB) and following a hypocaloric Mediterranean-like diet. (2) Methods: A prospective observational pilot study of 20 patients undergoing RYGB was conducted. The participants underwent a magnetic resonance spectroscopy study 2 weeks before the surgical act and one year postoperatively to assess the percentage of lipid content (PLC). The adherence to the Mediterranean diet was determined by the KIDMED test 1 year after surgery. (3) Results: Mean baseline PLC was 14.2 ± 9.4%, and one year after surgery, it decreased to 4.0 ± 1.8% (

Indexed as

Diet, MediterraneanGastric BypassMagnetic Resonance SpectroscopyObesity, MorbidAdultFemaleHumansMiddle AgedNon-alcoholic Fatty Liver DiseasePilot ProjectsPostoperative PeriodProspective StudiesTreatment Outcomeadherencebariatric surgeryliver steatosisMAFLDmagnetic resonance spect5roscopyMediterranean dietmetabolic-associated fatty liver diseasemorbid obesityRoux-en-Y gastric bypass

Identifiers

PMID39064723
PMCPMC11279620

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.